VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Collegium Pharmaceutical, Inc. (COLL) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Drug Manufacturers - Specialty & Generic · market value about $736M · P/E 19.3 · revenue $808M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows